Bausch Health
BHC
$8.99
Share price
-7.20%
Change (1 day)
-41.19%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - Total assets
Total assets on the balance sheet as of December 2024 : A$42.04 Billion
According to Bausch Health 's latest financial reports the company's total assets are A$42.04 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Bausch Health - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | A$42.64 B | 6.22% |
| 2023-12-31 | A$40.14 B | 6.35% |
| 2022-12-31 | A$37.74 B | -6.29% |
| 2021-12-31 | A$40.27 B | -0.73% |
| 2020-12-31 | A$40.57 B | -16.11% |
| 2019-12-31 | A$48.36 B | 4.86% |
| 2018-12-31 | A$46.12 B | -3.97% |
| 2017-12-31 | A$48.02 B | -20.46% |
| 2016-12-31 | A$60.38 B | -10.16% |
| 2015-12-31 | A$67.21 B | 109.12% |
| 2014-12-31 | A$32.14 B | 2.5% |
| 2013-12-31 | A$31.35 B | 81.54% |
| 2012-12-31 | A$17.27 B | 35.12% |
| 2011-12-31 | A$12.78 B | 20.29% |
| 2010-12-31 | A$10.62 B | 363.6% |
| 2009-12-31 | A$2.29 B | -0.38% |
| 2008-12-31 | A$2.30 B | 12.9% |
| 2007-12-31 | A$2.03 B | -26.71% |
| 2006-12-31 | A$2.78 B | 0.31% |
| 2005-12-31 | A$2.77 B | 25.4% |
| 2004-12-31 | A$2.21 B | -28.47% |
| 2003-12-31 | A$3.09 B | -5.03% |
| 2002-12-31 | A$3.25 B | 24.76% |
| 2001-12-31 | A$2.60 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 | A$28.8 M | -99.93% | 🇺🇸 USA |
 | A$3.48 B | -91.70% | 🇺🇸 USA |